Drug intelligence / Profile preview

Preservative-free investigational lubricating eye drops

Development stage: Phase 2
Lead developer: Johnson & Johnson
Modality: Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Ophthalmic

Overview

Preservative-free investigational lubricating eye drops are an ophthalmic solution designed to lubricate the ocular surface. These drops are being investigated for their potential to improve visual acuity in contact lens wearers and are delivered via a Novelia® eyedropper. The lead sponsor for its clinical investigation is Johnson & Johnson Vision Care, Inc.

Beyond the preview

Go deeper on Preservative-free investigational lubricating eye drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preservative-free investigational lubricating eye drops.

Explore the full profile